MSQOL

(redirected from Migraine-Specific Quality of Life)
AcronymDefinition
MSQOLMultiple Sclerosis Quality of Life (physical and mental health questionnaire)
MSQOLMigraine-Specific Quality of Life
References in periodicals archive ?
The Migraine-Specific Quality of Life Questionnaire, a 16-item disease-specific instrument, assesses aspects of health believed to be particularly affected by migraine.
Patients completed the Short Form-36 Health Survey, the Migraine-Specific Quality of Life Questionnaire, and the productivity/disability questionnaires on four occasions: at baseline and on visits 1, 2, and 3.
Each of the eight Short Form-36 Health Survey dimensions and the three Migraine-Specific Quality of Life Questionnaire dimensions were scored separately and transformed to a scale ranging from 0 (least favorable score) to 100 (most favorable score).
Linear regression analyses were used to produce adjusted scores for both the Short Form-36 Health Survey (scores adjusted for age; sex; race; baseline scores; and selected comorbidities, including arthritis, chronic obstructive pulmonary disease, back pain, hypertension, gastrointestinal distress, clinical depression, and urinary tract infection) and the Migraine-Specific Quality of Life Questionnaire (scores adjusted for age, sex, race, and baseline scores).
Repeated-measures analyses of variance were statistically significant (P<.001 ) for each of the three Migraine-Specific Quality of Life Questionnaire dimensions (Table 3).
Unlike some of the Short Form-36 Health Survey dimensions, the Migraine-Specific Quality of Life Questionnaire was sensitive to the effects of sumatriptan on aspects of health that are believed to be primarily affected by migraine.
That improvements in patient-reported productivity and reductions in disability over the course of the study were accompanied by improvements in health-related quality of life, measured with either the Short Form-36 Health Survey or the Migraine-Specific Quality of Life Questionnaire, supports this contention.
All participants completed (in the local language) the Migraine Disability Assessment Scale (MIDAS), the Headache Impact Test (HIT-6), and the Migraine-Specific Quality of Life Scale (MSQoL), to confirm the validity of the M-TOQ and to detect redundancy.